Screener
10x Genomics, Inc. TXG Total Cost of Revenue
Total Cost of Revenue at other companies
Other financials
Where this comes from
Reported directly by 10x Genomics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CostOfRevenue.
The source filing: 10x Genomics, Inc.’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054491
FAQ
- What is 10x Genomics, Inc.'s total cost of revenue?
- 10x Genomics, Inc. (TXG) reported total cost of revenue of $38.54M in Q2 2026.
- How has 10x Genomics, Inc.'s total cost of revenue changed year-over-year?
- 10x Genomics, Inc.'s total cost of revenue decreased by 19.4% year-over-year, from $47.82M to $38.54M.
- What is the long-term trend for 10x Genomics, Inc.'s total cost of revenue?
- Over 4 years (2021 to 2025), 10x Genomics, Inc.'s total cost of revenue has grown at a 28.0% compound annual growth rate (CAGR), from $74.09M to $198.94M.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.
Ask your AI about 10x Genomics, Inc.'s total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude